Sun Pharmaceutical Industries Ltd’s latest acquisition of US-based Checkpoint Therapeutics, Inc. is good news for its speciality business–an area of focus. Checkpoint is an immunotherapy and ...

Shares of Sun Pharmaceutical Industries Ltd. 524715 inched up 0.45% to 1,683.85 Indian rupees Thursday, on what proved to be an all-around rough trading session for the stock market, with the BSE ...

Takeda is sharpening its oncology focus amid an R&D revamp. Sun Pharma will acquire Checkpoint Therapeutics and an FDA-approved PD-L1 inhibitor. Japan's Ono Pharmaceutical bought an antisense ...

On Sunday, India-based Sun Pharmaceutical Industries Limited agreed to acquire U.S.-based immunotherapy and targeted oncology company Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) for an upfront ...

Sun Pharma Advanced Research Company Ltd share price was down by -4.22% from the previous closing price of ₹122.41. Who are peers of Sun Pharma Advanced Research Company Ltd? The peers of Sun ...

Sun Pharmaceutical Industries or Sun Pharma is India’s leading pharmaceutical firm which is known for the production of Active Pharmaceutical Ingredients (APIs). The company is headquartered in ...

‘The president is making a threat,’ an analyst tells the Sun, ‘and he has to be prepared to follow through on that threat if the Iranians and the Houthis keep defying him. He is not afraid to be ...

RCB Unbox Event 2025 Schedule: The RCB Unbox Event 2025 is set to be a grand spectacle as Royal Challengers Bengaluru (RCB) prepares to unveil its new jersey, introduce players, and celebrate its ...

The New Jersey Economic Development Authority (NJEDA) Board approved tax credits under the Emerge Program to support Sun Pharmaceutical Industries Inc.’s (Sun Pharma) plan to open a new US ...

The rise of artificial intelligence (AI), digitalisation, wider adoption of tools for marketing automation, and numerous other technologies have significantly reshaped the world of pharma for the ...

As one of the world’s biggest contributors to climate change, pharma is morally obliged to adapt its processes and operations – and doing so will open up new opportunities for growth.

The 21st century pharmaceutical and biotech sector has come a long way from its roots in 19th century pharmacy. pharmaphorum looks at its evolution over the centuries. The roots of the ...